Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bytes Technology announces £25m share buyback, shares spark

(Sharecast News) - Bytes Technology surged on Friday as the software, security, cloud and AI services specialist announced a share buyback programme of up to £25m. The company said its capital allocation policy "prioritises enhancing business growth, both organically and through select inorganic opportunities as they arise, whilst maintaining an appropriate level of liquidity headroom and returning excess capital to shareholders (through normal and special dividends, and share buybacks), where appropriate".

It also said the board continuously reviews capital allocation opportunities.

"After considering the company's strong balance sheet position and prevailing share price, the board believes that it would be beneficial to return capital to shareholders through a share repurchase," Bytes said.

At 1225 BST, the stock was up 8% at 390.40p.

Shares in Bytes Technology tumbled at the beginning of July after it warned that first-half operating profit was set to be "marginally" lower than last year, with customers delaying purchase decisions amid a "challenging" macro environment.

It said that trading across the first months of the year was impacted by a challenging macroeconomic environment which led to some deferral of customer buying decisions, particularly in the corporate sector.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.